BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $8.60 million. The enterprise value is -$2.47 million.
| Market Cap | 8.60M |
| Enterprise Value | -2.47M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 6.77 million shares outstanding. The number of shares has increased by 16.60% in one year.
| Shares Outstanding | 6.77M |
| Shares Change (YoY) | +16.60% |
| Shares Change (QoQ) | +2.55% |
| Owned by Insiders (%) | 18.80% |
| Owned by Institutions (%) | 13.80% |
| Float | 5.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.97 |
| Forward PS | 70.24 |
| PB Ratio | 0.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.71, with zero debt.
| Current Ratio | 10.71 |
| Quick Ratio | 10.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -114.70% and return on invested capital (ROIC) is -131.80%.
| Return on Equity (ROE) | -114.70% |
| Return on Assets (ROA) | -107.20% |
| Return on Capital (ROIC) | -131.80% |
| Revenue Per Employee | $13,255 |
| Profits Per Employee | -$1.31M |
| Employee Count | 11 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.91% in the last 52 weeks. The beta is 61.68, so BRTX's price volatility has been higher than the market average.
| Beta (1Y) | 61.68 |
| 52-Week Price Change | -65.91% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 1.90 |
| Relative Strength Index (RSI) | 47.86 |
| Average Volume (30 Days) | 675,898 |
Short Selling Information
The latest short interest is 40,500, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 40,500 |
| Short Previous Month | 19,868 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 0.74% |
| Short Ratio (days to cover) | 0.53 |
Income Statement
In the last 12 months, BRTX had revenue of $145,800 and -$14.42 million in losses. Loss per share was -$3.42.
| Revenue | 145,800 |
| Gross Profit | 145,800 |
| Operating Income | -15.22M |
| Pretax Income | -14.42M |
| Net Income | -14.42M |
| EBITDA | -14.16M |
| EBIT | -14.42M |
| Loss Per Share | -$3.42 |
Balance Sheet
The company has $11.07 million in cash and no debt, giving a net cash position of $11.07 million or $1.63 per share.
| Cash & Cash Equivalents | 11.07M |
| Total Debt | n/a |
| Net Cash | 11.07M |
| Net Cash Per Share | $1.63 |
| Equity / Book Value | 11.55M |
| Book Value Per Share | 1.71 |
| Working Capital | 10.33M |
Cash Flow
In the last 12 months, operating cash flow was -$6.43 million and capital expenditures -$171,043, giving a free cash flow of -$6.60 million.
| Operating Cash Flow | -6.43M |
| Capital Expenditures | -171,043 |
| Free Cash Flow | -6.60M |
| FCF Per Share | -$1.57 |
Margins
Gross margin is 100.00%, with operating and profit margins of -10,439.49% and -9,887.16%.
| Gross Margin | 100.00% |
| Operating Margin | -10,439.49% |
| Pretax Margin | -9,887.16% |
| Profit Margin | -9,887.16% |
| EBITDA Margin | -9,711.55% |
| EBIT Margin | -9,887.16% |
| FCF Margin | -4,527.61% |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.60% |
| Shareholder Yield | -16.60% |
| Earnings Yield | -167.66% |
| FCF Yield | -76.78% |
Analyst Forecast
The average price target for BRTX is $15.00, which is 1,081.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 1,081.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 321.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4000.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:4000 |
Scores
BRTX has an Altman Z-Score of -16.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.47 |
| Piotroski F-Score | 2 |